Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram

✍ Scribed by Lash, T L; Pedersen, L; Cronin-Fenton, D; Ahern, T P; Rosenberg, C L; Lunetta, K L; Silliman, R A; Hamilton-Dutoit, S; Garne, J P; Ewertz, M

• Book ID: 109999627
• Publisher: Nature Publishing Group
• Year: 2008
• Tongue: English
• Weight: 124 KB
• Volume: 99
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6604533